Management of adverse events related to first-generation tyrosine receptor kinase inhibitors in adults: a narrative review
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of adverse events related to first-generation tyrosine receptor kinase inhibitors in adults: a narrative review
Authors
Keywords
-
Journal
SUPPORTIVE CARE IN CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-03
DOI
10.1007/s00520-022-07401-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review
- (2021) Hannah C. Timmins et al. Journal of Cancer Survivorship
- Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
- (2021) Tiffany M. Powell-Wiley et al. CIRCULATION
- Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours
- (2021) L. Paz-Ares et al. ESMO Open
- Tropomyosin receptor kinase inhibitors: an updated patent review for 2016 – 2019
- (2020) Justin J Bailey et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
- (2020) David S Hong et al. LANCET ONCOLOGY
- Characterization of On-Target Adverse Events Caused by TRK Inhibitor Therapy
- (2020) D. Liu et al. ANNALS OF ONCOLOGY
- Entrectinib for the treatment of metastatic NSCLC: safety and efficacy
- (2020) Andrea Sartore-Bianchi et al. Expert Review of Anticancer Therapy
- Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up†
- (2020) B. Jordan et al. ANNALS OF ONCOLOGY
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
- (2020) Charles L. Loprinzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Antiemetics: ASCO Guideline Update
- (2020) Paul J. Hesketh et al. JOURNAL OF CLINICAL ONCOLOGY
- Larotrectinib in adult patients with solid tumours: a multicentre, open-label, phase I dose-escalation study
- (2019) D S Hong et al. ANNALS OF ONCOLOGY
- Larotrectinib: First Global Approval
- (2019) Lesley J. Scott DRUGS
- Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor for the treatment of TRK fusion cancer
- (2019) Noah Federman et al. Expert Review of Clinical Pharmacology
- TRK inhibitors in TRK fusion-positive cancers
- (2019) A Drilon ANNALS OF ONCOLOGY
- Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
- (2019) Robert C Doebele et al. LANCET ONCOLOGY
- Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines†
- (2018) P Bossi et al. ANNALS OF ONCOLOGY
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- NTRK fusion-positive cancers and TRK inhibitor therapy
- (2018) Emiliano Cocco et al. Nature Reviews Clinical Oncology
- TRK Inhibition: A New Tumor-Agnostic Treatment Strategy
- (2018) Shivaani Kummar et al. Targeted Oncology
- Managing adverse events associated with vismodegib in the treatment of basal cell carcinoma
- (2017) Kate Fife et al. Future Oncology
- Patient Counseling and Management of Symptoms During Olaparib Therapy for Recurrent Ovarian Cancer
- (2016) K. N. Moore et al. ONCOLOGIST
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- (2016) Mario E. Lacouture et al. ONCOLOGIST
- Guidance on the management of diarrhoea during cancer chemotherapy
- (2014) Jervoise Andreyev et al. LANCET ONCOLOGY
- A systematic review of dysgeusia induced by cancer therapies
- (2010) Allan J. Hovan et al. SUPPORTIVE CARE IN CANCER
- Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management
- (2009) Alexander Stein et al. Therapeutic Advances in Medical Oncology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now